Hebrews 5:12-14 (KJV) "For when for the time ye ought to be teachers, ye have need that one teach you again which be the first principles of the oracles of God; and are become such as have need of milk, and not of strong meat. For every one that useth milk is unskilful in the word of righteousness: for he is a babe. But strong meat belongeth to them that are of full age, even those who by reason of use have their senses exercised to discern both good and evil."
Proverbs 27:17 (KJV) "Iron sharpeneth iron; so a man sharpeneth the countenance of his friend."
Researchers in US reduced cholesterol levels in healthy mice treated in utero by targeting a gene that regulates those levels.
They also used prenatal gene editing to improve liver function and prevent neonatal death in a subgroup of mice. (Photo: AFP)
Washington: In a first, scientists have performed prenatal gene editing to prevent a lethal metabolic disorder in animals, offering the potential to treat human congenital diseases before birth.
Using both CRISPR-Cas9 and base editor 3 (BE3) gene-editing tools, researchers from University of Pennsylvania and Children's Hospital of Philadelphia (CHOP) in the US reduced cholesterol levels in healthy mice treated in utero by targeting a gene that regulates those levels.
They also used prenatal gene editing to improve liver function and prevent neonatal death in a subgroup of mice that had been engineered with a mutation causing the lethal liver disease hereditary tyrosinemia type 1 (HT1).
HT1 in humans usually appears during infancy, and it is often treatable with a medicine called nitisinone and a strict diet.
However, when treatments fail, patients are at risk of liver failure or liver cancer. Prenatal treatment could open a door to disease prevention, for HT1 and potentially for other congenital disorders.
"Our ultimate goal is to translate the approach used in these proof-of-concept studies to treat severe diseases diagnosed early in pregnancy," said William H Peranteau, a pediatric and foetal surgeon in CHOP's Center for Fetal Diagnosis and Treatment.
"We hope to broaden this strategy to intervene prenatally in congenital diseases that currently have no effective treatment for most patients, and result in death or severe complications in infants," said Peranteau.
"We used base editing to turn off the effects of a disease-causing genetic mutation," said Kiran Musunuru, an associate professor at University of Pennsylvania.
"We also plan to use the same base-editing technique not just to disrupt a mutation's effects, but to directly correct the mutation," said Musunuru.
In the study, scientists used base editor 3 (BE3), which takes clustered regularly interspersed short palindromic repeats (CRISPR), joins it with a modified CRISPR-associated protein 9 to form a partially active version of the CRISPR-Cas 9 tool, and harnesses it as a homing device to carry an enzyme to a highly specific genetic location in the liver cells of foetal mice.
The enzyme chemically modified the targeted genetic sequence, changing one type of DNA base to another. After birth, the mice in the study carried stable amounts of edited liver cells for up to three months after the prenatal treatment, with no evidence of unwanted, off-target editing at other DNA sites.
"A significant amount of work needs to be done before prenatal gene editing can be translated to the clinic, including investigations into more clinically relevant delivery mechanisms and ensuring the safety of this approach," Peranteau said.
AWFSM is the #1 source for christian faith based independent alternative news, views, & videos;
challenging the way we read the news. Our christian themed bi-monthly publication presents up to date inspiration, information, & exhortation. You will not find AWFSM like any other mainstream headline news site, nor like any other global alternative news feed. We at AWFSM endeavor to jumpstart your spirit and your mind together to be ignited & inspired fresh today!
DISCLAIMER: Important Notice
AWFSM is an independent non profit endeavor. This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. AWFSM presents news worthy material available in an effort to inspire a faith based understanding of our environment, politics, human rights, economics, science, & social justice issues; etc.; AWFSM believes this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. All material is protected according to general copyrights for all authors & used under the Fair Use Statements. AWFSM does not endorse any third party links. Any added scriptural references are by AWFSM. Please see AWFSM Mission Statement. Thank You.